Stock LQDA LIQUIDIA CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Liquidia Corporation

Equities

LQDA

US53635D2027

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
12.87 USD +0.08% Intraday chart for Liquidia Corporation +3.62% +6.98%
May. 15 Transcript : Liquidia Corporation Presents at Bank of America Health Care Conference 2024, May-14-2024 05:01 PM
May. 14 Transcript : Liquidia Corporation, Q1 2024 Earnings Call, May 14, 2024

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Liquidia Corporation to Present at the 2024 Jefferies Global Healthcare Conference
GL
Liquidia Corporation Reports First Quarter 2024 Financial Results and Provides Corporate Update
GL
Liquidia Announces Poster Presentation at the American Thoracic Society 2024 International Conference on Its Open-Label Safety Study of L606 in Patients with PAH and PH-ILD
AQ
Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-ILD
GL
Liquidia Corporation to Present at BofA Securities Health Care Conference 2024
GL
Liquidia Corporation to Present at BofA Securities Health Care Conference 2024
AQ
Liquidia Corporation to Report First Quarter 2024 Financial Results on May 14, 2024
GL
Liquidia Corporation to Report First Quarter 2024 Financial Results on May 14, 2024
AQ
Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference
GL
Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference
AQ
Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder
GL
Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate Update
GL
Liquidia Corporation to Report Full Year 2023 Financial Results on Wednesday, March 13, 2024
GL
Spotlight On Upcoming Oral Arguments – February 2024
AQ
Liquidia Corporation Announces Poster Presentation at the Pulmonary Vascular Research Institute 2024 Annual Congress
GL
Liquidia Corporation Provides Update on New Drug Application for YUTREPIA inhalation powder
AQ
Liquidia Corporation Provides Update on New Drug Application for YUTREPIA™ (treprostinil) inhalation powder
GL
Liquidia Corporation Announces Updates to Operations Leadership
GL
Liquidia Corporation Files Response to United Therapeutics Lawsuit and Files Counterclaims
GL
Liquidia Provides Update on Clinical Pipeline Targeting PAH and PH-ILD
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LQDA Stock
  4. News Liquidia Corporation
  5. Press Releases